Iovance Biotherapeutics Inc. buy The Goldman Sachs Group, Inc.
Start price
12.05.25
/
50%
€1.71
Target price
12.05.26
€7.13
Performance (%)
-13.42%
Price
04.07.25
€1.48
Summary
This prediction is currently active. The prediction for Iovance Biotherapeutics Inc. disappoints with a performance of -13.42%. This prediction currently runs until 12.05.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Iovance Biotherapeutics Inc. | 2.307% | 2.307% |
| iShares Core DAX® | -1.315% | -2.266% |
| iShares Nasdaq 100 | 0.272% | 1.449% |
| iShares Nikkei 225® | -2.496% | 1.560% |
| iShares S&P 500 | 0.504% | 1.340% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $16.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for IOVA provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€2.71
17.04.25
17.04.25
€14.08
17.04.26
17.04.26
-45.33%
04.07.25
04.07.25
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€3.90
03.03.25
03.03.25
€18.11
03.03.26
03.03.26
-62.02%
04.07.25
04.07.25
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€14.52
29.02.24
29.02.24
€19.38
28.02.25
28.02.25
-72.27%
01.03.25
01.03.25
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€11.80
20.02.24
20.02.24
€17.55
20.02.25
20.02.25
-53.22%
21.02.25
21.02.25
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€5.05
20.11.23
20.11.23
€10.98
20.11.24
20.11.24
53.15%
21.11.24
21.11.24